{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:32:39Z","timestamp":1648740759095},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00108-021-01069-y","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T08:05:09Z","timestamp":1625126709000},"page":"429-434","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["62\/m mit Diabetes mellitus Typ\u00a02"],"prefix":"10.1007","volume":"62","author":[{"given":"M.","family":"Menzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"3","key":"1069_CR1","doi-asserted-by":"publisher","first-page":"P512","DOI":"10.1016\/j.eururo.2005.05.014","volume":"48","author":"A Ponholzer","year":"2005","unstructured":"Ponholzer\u00a0A et\u00a0al (2005) Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 48(3):P512\u2013P518","journal-title":"Eur Urol"},{"key":"1069_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11428-021-00722-2","volume":"17","author":"D Ziegle","year":"2021","unstructured":"Ziegle\u00a0D, Keller\u00a0J, Maler\u00a0C, Pannek\u00a0J (2021) Diabetische Neuropathie. Diabetologe 17:179\u2013191","journal-title":"Diabetologe"},{"key":"1069_CR3","unstructured":"Pfizer (2021) Patient-centered outcomes assessment. https:\/\/www.pfizerpatientreportedoutcomes.com. Zugegriffen: 11.02.2021"},{"key":"1069_CR4","unstructured":"Informationszentrum f\u00fcr Sexualit\u00e4t und Gesundheit (2021) Webpr\u00e4senz. www.isg-info.de. Zugegriffen: 11.02.2021"},{"key":"1069_CR5","unstructured":"Johns MW (2021) The Epworth sleepiness scale. www.epworthsleepinessscale.com. Zugegriffen: 11.02.2021"},{"key":"1069_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9893-4_10","volume-title":"STOP, THAT and one hundred other sleep scales","author":"A Shahid","year":"2011","unstructured":"Shahid\u00a0A, Wilkinson\u00a0K, Marcu\u00a0S, Shapiro\u00a0CM (2011) Berlin questionnaire. In: Shahid\u00a0A, Wilkinson\u00a0K, Marcu\u00a0S, Shapiro\u00a0C (Hrsg) STOP, THAT and one hundred other sleep scales. Springer, New York https:\/\/doi.org\/10.1007\/978-1-4419-9893-4_10"},{"key":"1069_CR7","series-title":"Version 5","doi-asserted-by":"publisher","DOI":"10.6101\/AZQ\/000302","volume-title":"Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter \u2013 Langfassung","author":"Bundes\u00e4rztekammer","year":"2011","unstructured":"Bundes\u00e4rztekammer, Kassen\u00e4rztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2011) Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter \u2013 Langfassung, 1.\u00a0Aufl. Version 5. https:\/\/doi.org\/10.6101\/AZQ\/000302 (Available from: www.dm-neuropathie.versorgungsleitlinien.de)","edition":"1"},{"issue":"Suppl 1","key":"1069_CR8","first-page":"S175","volume":"15","author":"H Hammes","year":"2020","unstructured":"Hammes\u00a0H et\u00a0al (2020) Diabetische Retinopathie und Makulopathie Diabetologie. Diabetologe 15(Suppl 1):S175\u2013S180","journal-title":"Diabetologe"},{"key":"1069_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11428-021-00721-3","volume":"17","author":"L Merker","year":"2021","unstructured":"Merker\u00a0L, Bautsch\u00a0BW, Ebert\u00a0T et\u00a0al (2021) Nephropathie bei Diabetes. Diabetologe 17:175\u2013178","journal-title":"Diabetologe"},{"issue":"S 01","key":"1069_CR10","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1055\/a-1194-1745","volume":"15","author":"B Balletshofer","year":"2020","unstructured":"Balletshofer\u00a0B, B\u00f6ckler\u00a0D, Diener\u00a0H et al (2020) Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus \u2013 Gemeinsame Stellungnahme der Deutschen Diabetes Gesellschaft (DDG), der Deutschen Gesellschaft f\u00fcr Angiologie (DGA), der Deutschen Gesellschaft f\u00fcr Interventionelle Radiologie und minimal-invasive Therapie (DeGIR) sowie der Deutschen Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie und Gef\u00e4\u00dfmedizin (DGG). Diabetol Stoffwechs 15(S 01):S196\u2013S205","journal-title":"Diabetol Stoffwechs"},{"issue":"S 01","key":"1069_CR11","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1055\/a-1194-1790","volume":"15","author":"S Morbach","year":"2020","unstructured":"Morbach\u00a0S, Lobmann\u00a0R, Eckhard\u00a0M et\u00a0al (2020) Diabetisches Fu\u00dfsyndrom. Diabetol Stoffwechs 15(S 01):S206\u2013S215","journal-title":"Diabetol Stoffwechs"},{"issue":"5","key":"1069_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2337\/diacare.21.5.855","volume":"21","author":"DG Armstrong","year":"1998","unstructured":"Armstrong\u00a0DG, Lavery\u00a0LA, Harkless\u00a0LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21(5):855\u2013859","journal-title":"Diabetes Care"},{"issue":"2","key":"1069_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/107110078100200202","volume":"2","author":"FW Wagner Jr","year":"1981","unstructured":"Wagner\u00a0FW Jr (1981) The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2(2):64\u2013122","journal-title":"Foot Ankle"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01069-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T12:40:49Z","timestamp":1631536849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01069-y"}},"subtitle":["Vorbereitung auf die Facharztpr\u00fcfung: Fall\u00a064"],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":13,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01069-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"20 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M. Menzen: Finanzielle Interessen: Referentenhonorare\/Reisekosten: AstraZeneca, Boehringer Ingelheim, MSD, Novo Nordisk, Novartis, Eli Lilly, Deutsche Diabetes Gesellschaft, \u00c4rztekammer Nordrhein; bezahlter Berater\/interner Schulungsreferent: Novo Nordisk, Servier, Novartis, Bayer. Nichtfinanzielle Interessen: Chefarzt Innere Medizin\u00a0\u2013 Diabetologie, Gemeinschaftskrankenhaus Bonn; Mitgliedschaften: Deutsche Diabetes Gesellschaft, Deutsche Gesellschaft f\u00fcr Innere Medizin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}